Vaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovations
Authors:
- Mercy MvunduraMMMercy Mvundura
- Collrane FrivoldCFCollrane Frivold
- Anna Janik OsborneAOAnna Janik Osborne
- Joanie RobertsonJRJoanie Robertson
- Sandeep KumarSKSandeep Kumar
- Jacqueline AnenaJAJacqueline Anena
- Abdoulaye GueyeAGAbdoulaye Gueye
- Marion Menozzi-ArnaudMMMarion Menozzi-Arnaud
- Birgitte GiersingBGBirgitte Giersing
- Anna-Lea KahnAKAnna-Lea Kahn
- Tiziana ScarnaTSTiziana Scarna
Open Access
- 1 December 2021
- Vol. 39 (49) , 7195-7207
Abstract
No abstract availableKeywords
Funding Information
- Bill & Melinda Gates Foundation
This publication has 6 references indexed in Scilit:
- A global collaboration to advance vaccine product innovations – The Vaccine Innovation Prioritisation StrategyVaccine, 2021
- Global vaccine action plan lessons learned I: Recommendations for the next decadeVaccine, 2020
- Technologies to Improve Immunization2018
- Challenges of vaccine presentation and delivery: How can we design vaccines to have optimal programmatic impact?Vaccine, 2017
- Exploring new packaging and delivery options for the immunization supply chainVaccine, 2017
- What vaccine product attributes do immunization program stakeholders value? Results from interviews in six low- and middle-income countriesVaccine, 2016